Evercore ISI analyst Kirk Materne maintained a Buy rating on EverCommerce (EVCM – Research Report) on March 14 and set a price target of ...

Evercore ISI analyst Gavin Clark-Gartner maintained a Buy rating on Meiragtx Holdings (MGTX – Research Report) on March 14 and set a price ...

Carvana (NYSE:CVNA – Free Report) had its price target lowered by Evercore ISI from $250.00 to $240.00 in a report issued on ...

Oracle (NYSE:ORCL – Get Free Report) had its price target cut by equities researchers at Evercore ISI from $200.00 to $185.00 ...

On Wednesday, Evercore ISI upgraded Capital One Financial shares ... Additionally, BofA Securities upgraded Capital One’s stock rating to Buy, raising the price target to $235, reflecting ...

The Treasury secretary's muted reassurances to financial markets shows there may be no one in the administration willing to ...

Hinge Health announced that it has filed a registration statement on Form S-1 with the U.S. Securities and Exchange ...

On Wednesday, Evercore ISI upgraded Capital One Financial shares ... pending further regulatory approvals. Additionally, BofA Securities upgraded Capital One’s stock rating to Buy, raising the price ...

Mineralys Therapeutics, Inc. (Nasdaq: MLYS), a clinical-stage biopharmaceutical company focused on developing medicines to target hypertension, chronic kidney disease (CKD), obstructive sleep apnea ...

Morgan Stanley, Barclays and BofA Securities are acting as lead book-running managers for the proposed offering. Evercore ISI, RBC Capital Markets, Truist Securities, Stifel, William Blair ...

BofA Securities, Evercore ISI, Goldman Sachs & Co. LLC, Stifel and Wells Fargo Securities are acting as joint book-running managers for the offering. LifeSci Capital is acting as lead manager and ...